Dublin, May 10, 2021 (GLOBE NEWSWIRE) -- The "High Flow Oxygen Concentrators and Ventilators: Market Shares, Strategies, and Forecasts, Worldwide, 2021-2027" report from Wintergreen Research, Inc has ...
Use of high-flow oxygen was associated with less of a need for mechanical ventilation and a shorter time to recovery compared with conventional oxygen therapy in patients with severe COVID-19, a ...
SAN FRANCISCO -- Starting high-flow oxygen right away for young children with acute hypoxemic respiratory failure didn't help them leave the hospital sooner than standard oxygen therapy, the PARIS-2 ...
High-flow nasal oxygen therapy showed no benefit after cardiac surgery in a major trial. Learn more about the study.
NEWARK, Del, June 21, 2023 (GLOBE NEWSWIRE) -- The high-flow oxygen therapy devices market is forecast to expand at 0.5% CAGR over the estimated period, as per FMI's analysis. The industry's size is ...
Among ICU patients with acute hypoxemic respiratory failure, high-flow nasal oxygen reduced the incidence of intubation but did not significantly reduce 28-day mortality compared with standard oxygen ...
Please provide your email address to receive an email when new articles are posted on . Infants with bronchiolitis who are treated with high-flow oxygen therapy are less likely to require increased ...
Increased respiratory patient illness, COVID-19, and product recalls have created a critical need for ventilators in the United States, said David Shockley, Movair’s CEO, in a recent company press ...
Please provide your email address to receive an email when new articles are posted on . Children aged 1 to 4 years with acute hypoxemic respiratory failure did not experience shorter hospital stays on ...
Study finds that high-flow nasal oxygen therapy is as effective as traditional noninvasive ventilation and a better alternative (1 Trusted Source High-Flow Nasal Oxygen vs Noninvasive Ventilation in ...
Children, as well as their parents, may one day be able to breathe a little easier: The respiratory therapy company Vapotherm said a pilot study of its high-flow treatment showed it could outperform ...
The conclusion was that titrating oxygen administration to adequate levels, as recommended in guidelines, [1] is safer than administering oxygen at high flow rates to patients with COPD who may have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results